Bacterial genotoxins, gene methylation, and RNA interference: Pointing to colorectal cancer as an infectious disease?

References

• Søreide K, Janssen EA, Søiland H, Körner H, Baak JP. Microsatellite instability in colorectal cancer. Br J Surg 2006; 93: 395–406
   PubMed Web of Science ®Google Scholar
• Søreide K. Genetics and molecular classification of colorectal cancer. Tidsskr Nor Laegeforen 2007; 127: 2818–23
   PubMedGoogle Scholar
• Boland CR, Luciani MG, Gasche C, Goel A. Infection, inflammation, and gastrointestinal cancer. Gut 2005; 54: 1321–31
   PubMed Web of Science ®Google Scholar
• Niv Y, Goel A, Boland CR. JC virus and colorectal cancer: a possible trigger in the chromosomal instability pathways. Curr Opin Gastroenterol 2005; 21: 85–9
   PubMed Web of Science ®Google Scholar
• Damin DC, Caetano MB, Rosito MA, Schwartsmann G, Damin a, Frazzon A, et al. Evidence for an association of human papillomavirus infection and colorectal cancer. Eur J Surg Oncol 2007; 33: 569–74
   PubMed Web of Science ®Google Scholar
• Bodaghi S, Yamanegi K, Xiao SY, Da Costa M, Palefsky JM, Zheng Z-M. Colorectal papillomavirus infection in patients with colorectal cancer. Clin Cancer Res 2005; 11: 2862–7
   PubMed Web of Science ®Google Scholar
• Zumkeller N, Brenner H, Zwahlen M, Rothenbacher D. Helicobacter pylori infection and colorectal cancer risk: a meta-analysis. Helicobacter 2006; 11: 75–80
   PubMed Web of Science ®Google Scholar
• Lax AJ, Thomas W. How bacteria could cause cancer: one step at a time. Trends Microbiol 2002; 10: 293–9
   PubMed Web of Science ®Google Scholar
• Zalata KR, Nasif WA, Ming SC, Lotfy M, Nada NA, El-Hak NG, et al. p53, Bcl-2 and C-Myc expressions in colorectal carcinoma associated with schistosomiasis in Egypt. Cell Oncol 2005; 27: 245–53
   PubMed Web of Science ®Google Scholar
• Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512–9
   PubMed Web of Science ®Google Scholar
• Hecht G. In the beginning was Helicobacter pylori: roles for microbes in other intestinal disorders. Gastroenterology 2007; 132: 481–3
   PubMed Web of Science ®Google Scholar
• Green GL, Brostoff J, Hudspith B, Michael M, Mylonaki M, Rayment N, et al. Molecular characterization of the bacteria adherent to human colorectal mucosa. J Appl Microbiol 2006; 100: 460–9
   PubMed Web of Science ®Google Scholar
• Zheng J, Meng J, Zhao S, Singh R, Song W. Adherence to and invasion of human intestinal epithelial cells by Campylobacter jejuni and Campylobacter coli isolates from retail meat products. J Food Prot 2006; 69: 768–74
   PubMed Web of Science ®Google Scholar
• Kadhum HJ, Ball HJ, Oswald E, Rowe MT. Characteristics of cytotoxic necrotizing factor and cytolethal distending toxin producing Escherichia coli strains isolated from meat samples in Northern Ireland. Food Microbiol 2006; 23: 491–7
   PubMed Web of Science ®Google Scholar
• Dolara P, Luceri C, De Filippo C, Femia AP, Giovannelli L, Caderni G, et al. Red wine polyphenols influence carcinogenesis, intestinal microflora, oxidative damage and gene expression profiles of colonic mucosa in F344 rats. Mutat Res 2005; 591: 237–46
   PubMed Web of Science ®Google Scholar
• Hill MJ, Drasar BS, Aries VC, Crowther JS, Hawksworth G, Williams RE. Bacteria and aetiology of cancer of large bowel. Lancet 1971; 1: 95–100
   PubMed Web of Science ®Google Scholar
• Zumkeller N, Brenner H, Chang-Claude J, Hoffmeister M, Nieters A, Rothenbacher D. Helicobacter pylori infection, interleukin-1 gene polymorphisms and the risk of colorectal cancer: evidence from a case-control study in Germany. Eur J Cancer 2007; 43: 1283–9
   PubMed Web of Science ®Google Scholar
• Huycke MM, Gaskins HR. Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp Biol Med (Maywood) 2004; 229: 586–97
   PubMed Web of Science ®Google Scholar
• Swidsinski A, Khilkin M, Kerjaschki D, Schreiber S, Ortner M, Weber J, et al. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology 1998; 115: 281–6
   PubMed Web of Science ®Google Scholar
• Wang X, Huycke MM. Extracellular superoxide production by Enterococcus faecalis promotes chromosomal instability in mammalian cells. Gastroenterology 2007; 132: 551–61
   PubMed Web of Science ®Google Scholar
• Yang L, Pei Z. Bacteria, inflammation, and colon cancer. World J Gastroenterol 2006; 12: 6741–6
   PubMed Web of Science ®Google Scholar
• Søreide K, Janssen EA, Kørner H, Baak JP. Trypsin in colorectal cancer: molecular biological mechanisms of proliferation, invasion, and metastasis. J Pathol 2006; 209: 147–56
   PubMed Web of Science ®Google Scholar
• Søreide K. Proteinase-activated receptor 2 (PAR-2) in gastrointestinal and pancreatic pathophysiology, inflammation and neoplasia. Scand J Gastroenterol 2008. In press.
   Google Scholar
• Perri F, Cotugno R, Piepoli A, Merla A, Quitadamo M, Gentile A, et al. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. pylori infected patients and effect of eradication. Am J Gastroenterol 2007; 102: 1361–71
   PubMed Web of Science ®Google Scholar
• Oswald E, Nougayrede JP, Taieb F, Sugai M. Bacterial toxins that modulate host cell-cycle progression. Curr Opin Microbiol 2005; 8: 83–91
   PubMed Web of Science ®Google Scholar
• Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006; 124: 823–35
   PubMed Web of Science ®Google Scholar
• Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ. C-reactive protein and the risk of incident colorectal cancer. JAMA 2004; 291: 585–90
   PubMed Web of Science ®Google Scholar
• Hecht GA. Inflammatory bowel disease: live transmission. N Engl J Med 2008; 358: 528–30
   PubMed Web of Science ®Google Scholar
• Garrity-Park MM, Loftus EV, Jr, Bryant SC, Sandborn WJ, Smyrk TC. Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer. Am J Gastroenterol 2008; 103: 407–15
   PubMed Web of Science ®Google Scholar
• Suchy J, Klujszo-Grabowska E, Kladny J, Cybulski C, Wokołorcyx D, Szymański-Pasternak J, et al. Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk. BMC Cancer 2008; 8: 112
   PubMed Web of Science ®Google Scholar
• Burstein E, Fearon ER. Colitis and cancer: a tale of inflammatory cells and their cytokines. J Clin Invest 2008; 118: 464–7
   PubMed Web of Science ®Google Scholar
• Hope ME, Hold GL, Kain R, El-Omar EM. Sporadic colorectal cancer: role of the commensal microbiota. FEMS Microbiol Lett 2005; 244: 1–7
   PubMed Web of Science ®Google Scholar
• Itzkowitz SH. Molecular biology of dysplasia and cancer in inflammatory bowel disease. Gastroenterol Clin North Am 2006; 35: 553–71
   PubMed Web of Science ®Google Scholar
• Fantini MC, Pallone F. Cytokines: from gut inflammation to colorectal cancer. Curr Drug Targets 2008; 9: 375–80
   PubMed Web of Science ®Google Scholar
• Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004; 287: G7–17
   PubMed Web of Science ®Google Scholar
• Travaglione S, Fabbri A, Fiorentini C. The Rho-activating CNF1 toxin from pathogenic E. coli: a risk factor for human cancer development?. Infect Agent Cancer 2008; 3: 4
   PubMedGoogle Scholar
• Wang D, DuBois RN. Inflammatory mediators and nuclear receptor signaling in colorectal cancer. Cell Cycle 2007; 6: 682–5
   PubMed Web of Science ®Google Scholar
• Smith JL, Bayles DO. The contribution of cytolethal distending toxin to bacterial pathogenesis. Crit Rev Microbiol 2006; 32: 227–48
   PubMed Web of Science ®Google Scholar
• Søreide K, Buter TC, Janssen EA, van Diermen B, Baak JP. A monotonous population of elongated cells (MPECs) in colorectal adenoma indicates a high risk of metachronous cancer. Am J Surg Pathol 2006; 30: 1120–9
   PubMed Web of Science ®Google Scholar
• Søreide K, Buter TC, Janssen EA, Gudlaugsson E, Skaland I, Körner H, et al. Cell-cycle and apoptosis regulators (p16INK4A, p21CIP1, beta-catenin, survivin, and hTERT) and morphometry-defined MPECs predict metachronous cancer development in colorectal adenoma patients. Cell Oncol 2007; 29: 301–13
   PubMed Web of Science ®Google Scholar
• Søreide K, Gudlaugsson E, Skaland I, Janssen EA, Van Diermen B, Körner H, , et al. Metachronous cancer development in patients with sporadic colorectal adenomas-multivariate risk model with independent and combined value of hTERT and survivin. Int J Colorectal Dis 2008;23:389–400.
   PubMed Web of Science ®Google Scholar
• Ge Z, Rogers AB, Feng Y, Lee A, Xu S, Taylor NS, et al. Bacterial cytolethal distending toxin promotes the development of dysplasia in a model of microbially induced hepatocarcinogenesis. Cell Microbiol 2007; 9: 2070–80
   PubMed Web of Science ®Google Scholar
• Nesic D, Hsu Y, Stebbins CE. Assembly and function of a bacterial genotoxin. Nature 2004; 429: 429–33
   PubMed Web of Science ®Google Scholar
• Taieb F, Nougayrede JP, Watrin C, Samba-Louaka A, Oswald E. Escherichia coli cyclomodulin Cif induces G2 arrest of the host cell cycle without activation of the DNA-damage checkpoint-signalling pathway. Cell Microbiol 2006; 8: 1910–21
   PubMed Web of Science ®Google Scholar
• Asakura M, Hinenoya A, Alam MS, Shima K, Zahid SH, Shi L, et al. An inducible lambdoid prophage encoding cytolethal distending toxin (Cdt-I) and a type III effector protein in enteropathogenic Escherichia coli. Proc Natl Acad Sci USA 2007; 104: 14483–8
   PubMed Web of Science ®Google Scholar
• Pitari GM, Zingman LV, Hodgson DM, Alekseev AE, Kazerounian S, Bienengraeber M, et al. Bacterial enterotoxins are associated with resistance to colon cancer. Proc Natl Acad Sci USA 2003; 100: 2695–9
   PubMed Web of Science ®Google Scholar
• Carrithers SL. Diarrhea or colorectal cancer: can bacterial toxins serve as a treatment for colon cancer?. Proc Natl Acad Sci USA 2003; 100: 3018–20
   PubMed Web of Science ®Google Scholar
• Li P, Schulz S, Bombonati A, Palazzo JP, Hyslop TM, Xu Y, et al. Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity. Gastroenterology 2007; 133: 599–607
   PubMed Web of Science ®Google Scholar
• Xiang S, Fruehauf J, Li CJ. Short hairpin RNA-expressing bacteria elicit RNA interference in mammals. Nat Biotechnol 2006; 24: 697–702
   PubMed Web of Science ®Google Scholar
• van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002; 111: 241–50
   PubMed Web of Science ®Google Scholar